A. Woetmann et al., Inhibition of protein phosphatase 2A induces serine/threonine phosphorylation, subcellular redistribution, and functional inhibition of STAT3, P NAS US, 96(19), 1999, pp. 10620-10625
Citations number
38
Categorie Soggetti
Multidisciplinary
Journal title
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Signal transducers and activators of transcription (STATs) are rapidly phos
phorylated on tyrosine residues in response to cytokine and growth factor s
timulation of cell surface receptors. STATs hereafter are translocated to t
he nucleus where they act as transcription factors. Recent reports suggest
that serine phosphorylation of STATs also is involved in the regulation of
STAT-mediated gene transcription. Here, we studied the role of serine/threo
nine phosphatases in STAT3 signaling in human antigen-specific CD4(+) T cel
l lines and cutaneous T cell lymphoma lines, expressing a constitutively ac
tivated STAT3. We show that an inhibitor of protein phosphatases (PPs) PP1/
PP2A, calyculin A, induces (i) phosphorylation of STAT3 on serine and threo
nine residues, (ii) inhibition of STAT3 tyrosine phosphorylation and DNA bi
nding activity, and (iii) relocation of STAT3 From the nucleus to the cytop
lasm. Similar results were obtained with other PP2A inhibitors (okadaic aci
d, endothall thioanhydride) but not with inhibitors of PP1 (tautomycin) or
PP2B (cyclosporine A). Pretreatment with the broad serine/threonine kinase
inhibitor staurosporine partly blocked the calyculin A-induced STAT3 phosph
orylation, whereas inhibitors of serine/threonine kinases, such as mitogen-
activated protein kinase-1 extracellular-regulated kinase-kinase, mitogen-a
ctivated protein p38 kinase, and phosphatidy/inositol 3-kinase, did not. In
conclusion, we provide evidence that PP2A plays a crucial role in the regu
lation of STAT3 phosphorylation and subcellular distribution in T cells. Mo
reover, our findings suggest that the level of STAT3 phosphorylation is bal
anced between a staurosporine-sensitive kinase(s) and PP2A.